US 8022041
Prodrug of an ICE inhibitor
granted A61KA61K38/00A61P
Quick answer
US patent 8022041 (Prodrug of an ICE inhibitor) held by Vertex Pharmaceuticals Incorporated expires Mon Sep 15 2031 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Vertex Pharmaceuticals Incorporated
- Grant date
- Tue Sep 20 2011 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Sep 15 2031 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 3
- CPC classes
- A61K, A61K38/00, A61P, A61P1/00, A61P1/02